China-headquartered Lilly Asia Ventures has backed an $18 million seed extension round for US-based Rgenta Therapeutics. In a separate development, IntoCare Medical Technology (Suzhou) Co., Ltd has raked in nearly 100 million yuan ($15 million) in a Series D round of financing led by Qiming Venture Partners.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
